Avalvi: INR Tracker & Dose Log
Avalvi Care INR is a health tracking app for patients on anticoagulation therapy, providing INR logging and TTR statistics on iOS and Android.
The App DNA
What makes this app unique?
The app removes the cognitive burden of manual therapy tracking by automating TTR calculations and generating professional reports for doctor visits, displacing paper-based logs.
For Patients managing long-term anticoagulant therapy who require precise tracking of INR levels and medication adherence.
What does it look like?
Key features
Automatically calculates Time in Therapeutic Range to measure therapy stability.
Stores all health records locally on the device without cloud synchronization.
Exports INR history and dose logs into professional PDF documents.
How much does it cost?
The freemium model relies on ad-supported free access, which currently drives user churn due to high ad frequency.
Velocity
Maintenance developmentinternationalizationperformanceShow more...
Avalvi: INR Tracker & Dose Log exhibits a maintenance-level development cadence, with three releases distributed over the last several months. The latest release expanded language support, while previous updates were limited to minor bug fixes and performance improvements. Development appears stable but slow, with no evidence of aggressive feature expansion or live operations. The current release pattern suggests a focus on basic platform upkeep and accessibility rather than rapid iteration.
Who built it?
Artur Skwarek
8 apps tracked · Health & Fitness
Sleep monitoring 2
Any photo puzzle
My present location
Avalvi Care Blood Sugar
Snoring monitoring
INR Tracker & INR Monitor
Snoring MonitoringUser Sentiment
What do users think recently?
Fresh user feedback skews mixed. Users appreciate the core functionality provides helpful tracking for users managing their health and inr levels.
How are ratings & reviews evolving?
What users say, by theme
- The core functionality provides helpful tracking for users managing their health and INR levels
- Excessive advertising frequency disrupts the user experience and forces some to abandon the application
4 of 4 recent reviews analyzed · limited sample
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Avalvi: INR Tracker & Dose Log
How's the Health & Fitness market?
Avalvi Care INR occupies a niche in the Health & Fitness category, focusing on privacy-conscious patients. The app maintains a 5-star rating on iOS, though the total review count remains low, signaling a need for broader user acquisition to validate the current monetization model.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Avalvi: INR Tracker & Dose Log
Where is it heading?
The anticoagulation tracking market is consolidating around tools that offer seamless, ad-free experiences for long-term patients. Avalvi Care INR remains exposed to churn as long as the ad-supported model disrupts the daily logging habit, which is the primary utility for its target audience.
- High ad frequency in the latest version disrupts the logging workflow, which directly correlates with user abandonment in recent reviews.
- The release cadence remains in maintenance mode, focusing on internationalization rather than addressing core feature requests like custom INR ranges.
The SWOT
- Local-first data storage ensures 100% privacy for sensitive health records
- TTR statistics provide objective therapy stability metrics
- Introducing a subscription-based ad-free tier could capture users currently churning due to ad density
Next best moves
Introduce a one-time purchase or subscription to remove ads because high ad frequency is the #1 complaint → increase retention
+ 1 more prioritized moveThe counter-intuitive read
The app's maintenance-mode cadence is a strategic advantage for a medical tool…
Read the full takeSince the last report: The app's competitive assessment has shifted from passive observation to an active recommendation for monetization reform. The analysis now frames the maintenance-mode cadence as a direct threat to market share in the face of consolidating anticoagulation tracking tools.
Bottom line
Transitioning to a subscription-based ad-free model would address the primary churn driver while unlocking recurring revenue, as the current ad-heavy freemium approach is actively eroding the user base.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store listing and user reviews
Report last updated